Status:
COMPLETED
Targeting HIV Retention and Improved Viral Load Through Engagement ('THRIVE')
Lead Sponsor:
Baylor College of Medicine
Collaborating Sponsors:
University of Iowa
Brown University
Conditions:
Human Immunodeficiency Virus
Depression
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Many people with HIV infection are not consistently engaged in outpatient HIV care, and avoidance, stigma and denial contribute to poor engagement in HIV care. This project will develop and pilot test...
Detailed Description
Poor retention in HIV primary care results in lower rates of HIV viral suppression, higher rates of HIV transmission, and exacerbates racial and ethnic disparities in health outcomes, including surviv...
Eligibility Criteria
Inclusion
- Hospitalized at Ben Taub Hospital, Houston, TX;
- at least 18 years of age;
- able to speak English or Spanish;
- HIV infected;
- able to provide informed consent and participate in the study (patients who are temporarily unable to participate will be followed and approached for enrollment if and when they are cognitively and physically capable of consenting and participating);
- HIV VL\>1000 c/mL;
- never in care or currently out of HIV care, defined as not meeting the 'visit constancy' measure (≥1 completed HIV primary care visit at Thomas Street Health Center (TSHC), Houston, TX, in each of the three 4-month intervals preceding admission); or ≥2 "no shows" to HIV primary care visits at TSHC in the last year.
- endorse one of two avoidance coping statements with the highest factor loadings on the Avoidant Coping Subscale from the Coping with HIV/AIDS scale
Exclusion
- intending to use a source of HIV primary care other than TSHC after discharge, because their outcomes cannot be evaluated;
- in the opinion of the primary medical team caring for the patient, likely to be discharged to an institutional setting, die in the hospital or enter hospice;
- incarcerated or expected to be discharged to prison or jail;
- enrolled in another research study with prospective follow-up;
- pregnant, since pregnant women receive additional efforts to be linked and retained in care;
- admitted with acute psychosis which would preclude informed consent or meaningful participation with the intervention.
Key Trial Info
Start Date :
March 3 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 29 2024
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT04481373
Start Date
March 3 2021
End Date
February 29 2024
Last Update
October 14 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ben Taub Hospital
Houston, Texas, United States, 77030